New York, NY, April 25, 2023 (GLOBE NEWSWIRE) -- SCWorx Corp. (Nasdaq: WORX) today announced that it has signed another new healthcare provider for its SaaS data management service offering and Workday implementation assistance.
This new hospital customer, headquartered in New York, is a non-profit academic healthcare provider with over 400 beds under management. In addition to the company’s data management service offering the hospital will utilize SCWorx expertise and application functionality to assist with the hospital’s Workday implementation.
“SCWorx is providing this new customer with our Foundation data management platform. This platform is continuing to be recognized as an advanced application that empowers hospitals to accurately move data between supply, clinical and finance applications. Accurate data enables hospitals to track information about items for proper revenue capture. In addition, this data can be used to enable other applications to perform better.”, said Tim Hannibal, SCWorx CEO. Hannibal added, “The foundational data principle is that all applications work more effectively with accurate data. This is why this healthcare provider chose SCWorx for data management as well as Workday implementation assistance. Workday is a transformational experience for a healthcare provider and the best way to start is with the highest quality data. More and more healthcare organizations are selecting and implementing Workday as their enterprise resource planning solution. SCWorx is a valuable application and partner for this very significant implementation. This is another great customer win for SCWorx and continues to demonstrate the value SCWorx brings to hospitals.”
About SCWorx
SCWorx has created an advanced attributed virtualized item data warehouse utilizing machine learning and artificial intelligence to offer a suite of software-as-a-service-based solutions for healthcare providers. The value proposition for customers revolves around the full integration of all solution modules with the company’s data platform for cost savings, operational efficiency and accurate benchmarking and reporting. The solution modules include Virtual Item Master, data cleanse and normalization, contract management and request for pricing (RFP) module, automated rebate management module, data interoperability (EMR, MMIS, finance) module, Automated Item Add Portal, Virtual General Ledger, and the data analytics module. SCWorx creates a single source for information for the healthcare provider’s data governance and analytics requirements.
Forward-Looking Statements
This press release contains “forward-looking statements” that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations, future contract renewals and terminations, future financial position, prospects, plans and objectives of management are forward-looking statements. You can identify many (but not all) such forward-looking statements by looking for words such as “assumes,” “approximates,” “believes,” “expects,” “anticipates,” “estimates,” “projects,” “seeks,” “intends,” “plans,” “could,” “would,” “may” or other similar expressions. You should not place undue reliance on these forward-looking statements. Such statements are based on management’s current expectations and involve risks and uncertainties. Actual results and performance could differ materially from those projected in the forward-looking statements as a result of many factors, including, without limitation, economic disruptions affecting our customers, unexpected contract terminations, securing future contracts and orders, future product sourcing, supply disruptions, containing costs, the ability to project future cash utilization and reserves needed for contingent future liabilities and business operations, the availability of sufficient resources of the company to meet its business objectives and operational requirements and other important factors that are detailed in filings with the Securities and Exchange Commission made from time to time by SCWorx, including its Annual Report on Form 10-K for the year ended December 31, 2021, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. Matters described in forward-looking statements may also be affected by other known and unknown risks, trends, uncertainties and factors, many of which are beyond the company’s ability to control or predict. SCWorx undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Contacts:
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$1.58 |
Daily Change: | -0.05 -3.07 |
Daily Volume: | 17,942 |
Market Cap: | US$2.940M |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB